Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin
Placental malaria is caused by Plasmodium falciparum–infected erythrocytes that bind to placental tissue. Binding is mediated by VAR2CSA, a parasite antigen coded by the var gene, which interacts with chondroitin sulfate A (CSA). Consequences include maternal anemia and fetal growth retardation. Ant...
Main Authors: | Nicaise Tuikue Ndam, Lise Denoeud-Ndam, Justin Doritchamou, Firmine Viwami, Ali Salanti, Morten A. Nielsen, Nadine Fievet, Achille Massougbodji, Adrian J.F. Luty, Philippe Deloron |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2015-05-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/21/5/14-1626_article |
Similar Items
-
Progress and Insights Toward an Effective Placental Malaria Vaccine
by: Benoît Gamain, et al.
Published: (2021-02-01) -
Plasmodium falciparum VAR2CSA-Specific IgG Subclass Responses Reflect Protection Against Low Birth Weight and Pregnancy-Associated Malaria
by: Bernard Tornyigah, et al.
Published: (2021-04-01) -
Can complement fix placental malaria?
by: Justin Y. A. Doritchamou, et al.
Published: (2021-09-01) -
Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine
by: Jasmita Gill, et al.
Published: (2021-11-01) -
Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens
by: Chathura Siriwardhana, et al.
Published: (2017-09-01)